Regenxbio (RGNX) Operating Margin Growth (3y) (2017 - 2025)

Regenxbio (RGNX) Operating Margin Growth (3y) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Regenxbio 528.62 Mn 298.55 Mn 21.22 Mn -2,800.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,800.00
Sep 30, 2025 9,170.00
Jun 30, 2025 -10,473.00
Mar 31, 2025 33,586.00
Dec 31, 2024 -32,081.00
Sep 30, 2024 -7,019.00
Jun 30, 2024 -1,950.00
Mar 31, 2024 -18,298.00
Dec 31, 2023 -3,750.00
Sep 30, 2023 -23,877.00
Jun 30, 2023 -11,344.00
Mar 31, 2023 -13,201.00
Dec 31, 2022 15,835.00
Sep 30, 2022 -2,378.00
Jun 30, 2022 27,633.00
Mar 31, 2022 373,983.00
Dec 31, 2021 7,266.00
Sep 30, 2021 24,193.00
Jun 30, 2021 -25,288.00
Mar 31, 2021 -31,029.00